Literature DB >> 2243962

Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.

J R Alger1, J A Frank, A Bizzi, M J Fulham, B X DeSouza, M O Duhaney, S W Inscoe, J L Black, P C van Zijl, C T Moonen.   

Abstract

Localized hydrogen-1 magnetic resonance (MR) spectroscopy and fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) were employed to obtain metabolic information from intracranial gliomas. Advantages and difficulties associated with comparison of results from the two modalities were realized. Forty patients were studied with H-1 MR spectroscopy. MR signal intensities from lactate, N-acetylaspartate (NAA), choline, and creatine from a volume of interest containing the tumor and a contralateral volume were obtained and evaluated. NAA signal intensities were generally decreased in the tumor spectra, and choline signal intensities were elevated. H-1 MR spectroscopy was unsuccessful in eight patients, and FDG PET scans were not obtained in four of the patients with successful MR spectroscopic examinations. Lactate signal intensity was detected in 10 of the 28 patients who had successful H-1 MR spectroscopic and FDG PET studies. Lactate signal intensities were observed in lesions shown at FDG PET to be hypermetabolic, as well as in lesions found to be hypometabolic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2243962     DOI: 10.1148/radiology.177.3.2243962

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  36 in total

Review 1.  MR spectroscopy and spectroscopic imaging of the brain.

Authors:  He Zhu; Peter B Barker
Journal:  Methods Mol Biol       Date:  2011

2.  Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings.

Authors:  I Chan Chiang; Yu-Ting Kuo; Chia-Ying Lu; Kwok-Wan Yeung; Wei-Chen Lin; Feng-O Sheu; Gin-Chung Liu
Journal:  Neuroradiology       Date:  2004-07-09       Impact factor: 2.804

Review 3.  Imaging radiation response in tumor and normal tissue.

Authors:  Marjan Rafat; Rehan Ali; Edward E Graves
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

4.  Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo.

Authors:  Xiaojuan Li; Daniel B Vigneron; Soonmee Cha; Edward E Graves; Forrest Crawford; Susan M Chang; Sarah J Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

5.  Method to correlate 1H MRSI and 18FDG-PET.

Authors:  J O'Neill; J L Eberling; N Schuff; W Jagust; B Reed; G Soto; F Ezekiel; G Klein; M W Weiner
Journal:  Magn Reson Med       Date:  2000-02       Impact factor: 4.668

6.  Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives.

Authors:  A Falini; G Calabrese; D Origgi; S Lipari; F Triulzi; M Losa; G Scotti
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

7.  The correlation between 1H MRS choline concentrations and MR diffusion trace values in human brain tumors.

Authors:  Dita Wagnerova; Filip Jiru; Monika Dezortova; Lydie Vargova; Eva Sykova; Milan Hajek
Journal:  MAGMA       Date:  2008-10-25       Impact factor: 2.310

8.  Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.

Authors:  Suja Saraswathy; Forrest W Crawford; Kathleen R Lamborn; Andrea Pirzkall; Susan Chang; Soonmee Cha; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-09-23       Impact factor: 4.130

Review 9.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

10.  Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas.

Authors:  Remy Guillevin; Carole Menuel; Hugues Duffau; Michel Kujas; Laurent Capelle; Agnès Aubert; Sophie Taillibert; Ahmed Idbaih; Joan Pallud; Giovanni Demarco; Robert Costalat; Khê Hoang-Xuan; Jacques Chiras; Jean-Noel Vallée
Journal:  J Neurooncol       Date:  2007-12-28       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.